Piga, Felisa M.

HRN: 27-13-49  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/16/2026
04/23/2026
IV
4.5g
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines